Gordon F. Schwartz

7.0k total citations
125 papers, 5.3k citations indexed

About

Gordon F. Schwartz is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Gordon F. Schwartz has authored 125 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Cancer Research, 59 papers in Pathology and Forensic Medicine and 46 papers in Oncology. Recurrent topics in Gordon F. Schwartz's work include Breast Cancer Treatment Studies (76 papers), Breast Lesions and Carcinomas (57 papers) and Breast Implant and Reconstruction (23 papers). Gordon F. Schwartz is often cited by papers focused on Breast Cancer Treatment Studies (76 papers), Breast Lesions and Carcinomas (57 papers) and Breast Implant and Reconstruction (23 papers). Gordon F. Schwartz collaborates with scholars based in United States, Italy and United Kingdom. Gordon F. Schwartz's co-authors include Umberto Veronesi, Armando E. Giuliano, Stephen A. Feig, Arthur S. Patchefsky, Anne Rosenberg, Lydia Komarnicky, Carl M. Mansfield, Lawrence J. Solin, Ivo A. Olivotto and Gabriel N. Hortobágyi and has published in prestigious journals such as JAMA, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Gordon F. Schwartz

120 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon F. Schwartz United States 40 3.6k 2.7k 1.9k 1.2k 826 125 5.3k
S. Eva Singletary United States 40 2.5k 0.7× 1.7k 0.6× 1.8k 1.0× 1.6k 1.3× 571 0.7× 84 4.8k
Nora Hansen United States 35 4.1k 1.2× 3.0k 1.1× 1.9k 1.0× 2.5k 2.1× 652 0.8× 112 5.8k
C.W. Elston United Kingdom 34 2.1k 0.6× 1.7k 0.7× 1.7k 0.9× 440 0.4× 632 0.8× 89 4.0k
David W. Kinne United States 43 2.9k 0.8× 2.4k 0.9× 2.7k 1.5× 1.0k 0.8× 512 0.6× 112 6.0k
Isabel T. Rubio Spain 32 2.9k 0.8× 1.8k 0.7× 1.8k 1.0× 1.1k 0.9× 573 0.7× 132 4.5k
Mauro G. Mastropasqua Italy 38 2.9k 0.8× 1.3k 0.5× 2.5k 1.3× 596 0.5× 657 0.8× 96 4.6k
R. Douglas Macmillan United Kingdom 38 2.1k 0.6× 1.1k 0.4× 2.4k 1.3× 1.1k 0.9× 1.0k 1.2× 75 4.8k
James Geraghty Ireland 28 2.1k 0.6× 1.6k 0.6× 1.0k 0.5× 1.4k 1.1× 305 0.4× 102 3.5k
Bernd Gerber Germany 38 4.4k 1.2× 1.8k 0.7× 3.9k 2.1× 1.4k 1.1× 975 1.2× 140 7.3k
Karin Zedeler Denmark 22 2.6k 0.7× 1.5k 0.6× 1.5k 0.8× 1.1k 0.9× 177 0.2× 34 3.5k

Countries citing papers authored by Gordon F. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Gordon F. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon F. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon F. Schwartz more than expected).

Fields of papers citing papers by Gordon F. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon F. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon F. Schwartz. The network helps show where Gordon F. Schwartz may publish in the future.

Co-authorship network of co-authors of Gordon F. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon F. Schwartz. A scholar is included among the top collaborators of Gordon F. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon F. Schwartz. Gordon F. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Epstein, Joel B., et al.. (2015). OUTPATIENT MEDICATION USE AND IMPLICATIONS FOR DENTAL CARE: GUIDANCE FOR CONTEMPORARY DENTAL PRACTICE.. PubMed. 81. f10–f10. 11 indexed citations
2.
Schwartz, Gordon F., Harry Bartelink, Harold J. Burstein, et al.. (2012). Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping. The Breast Journal. 18(4). 303–311. 11 indexed citations
3.
Witkiewicz, Agnieszka K., Dayana B. Rivadeneira, Adam Ertel, et al.. (2011). Association of RB/p16-Pathway Perturbations with DCIS Recurrence. American Journal Of Pathology. 179(3). 1171–1178. 41 indexed citations
4.
Chervoneva, Inna, et al.. (2011). Prognostic markers and long‐term outcomes in ductal carcinoma in situ of the breast treated with excision alone. Cancer. 117(16). 3650–3657. 37 indexed citations
5.
Balleine, Rosemary L., Sean Davis, Elizabeth Salisbury, et al.. (2008). Molecular Grading of Ductal Carcinoma In situ of the Breast. Clinical Cancer Research. 14(24). 8244–8252. 47 indexed citations
6.
Schwartz, Gordon F.. (2008). Consensus Conference on Breast Conservation. Journal of the American College of Surgeons. 206(6). 1239–1240. 1 indexed citations
7.
Schwartz, Gordon F., Umberto Veronesi, Krishna B. Clough, et al.. (2006). Consensus Conference on Breast Conservation. Journal of the American College of Surgeons. 203(2). 198–207. 68 indexed citations
8.
Cornfield, Dennis B., Juan Palazzo, Gordon F. Schwartz, et al.. (2004). The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast. Cancer. 100(11). 2317–2327. 82 indexed citations
9.
Schwartz, Gordon F. & Stephen A. Feig. (2002). Nonpalpable breast lesions: biopsy methods and patient management. Obstetrics and Gynecology Clinics of North America. 29(1). 137–157. 5 indexed citations
10.
Schwartz, Gordon F., Lawrence J. Solin, Ivo A. Olivotto, Virginia L. Ernster, & Peter Pressman. (2000). The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22–25, 1999. Human Pathology. 31(2). 131–139. 33 indexed citations
11.
Heron, Dwight E., Lydia Komarnicky, Terry Hyslop, Gordon F. Schwartz, & Carl M. Mansfield. (2000). Bilateral breast carcinoma. Cancer. 88(12). 2739–2750. 136 indexed citations
12.
Heron, Dwight E., Lydia Komarnicky, Terry Hyslop, Gordon F. Schwartz, & Carl M. Mansfield. (2000). Bilateral breast carcinoma. Cancer. 88(12). 2739–2750. 15 indexed citations
13.
Schwartz, Gordon F.. (2000). The Role of Radiotherapy in Ductal Carcinoma in Situ of the Breast. The Breast Journal. 6(5). 315–316. 1 indexed citations
14.
Schwartz, Gordon F.. (1996). Breast Conservation Following Induction Chemotherapy for Locally Advanced Breast Cancer: A Personal Experience. The Breast Journal. 2(1). 78–82. 3 indexed citations
15.
Schwartz, Gordon F.. (1996). Sub-Clinical Ductal Carcinoma In Situ of the Breast: Selection for Treatment by Local Excision and Surveillance Alone. The Breast Journal. 2(1). 41–44. 2 indexed citations
16.
Komarnicky, Lydia, et al.. (1996). 1059 Bilateral breast cancer: An evaluation of risk factors and outcome. International Journal of Radiation Oncology*Biology*Physics. 36(1). 273–273. 1 indexed citations
17.
Schwartz, Gordon F., et al.. (1994). Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer. 73(2). 362–369. 203 indexed citations
18.
Sa, Feig & Gordon F. Schwartz. (1981). Advantages and limitations of physical examination and mammography in breast cancer screening.. PubMed. 4(1-4). 553–63. 2 indexed citations
19.
Schwartz, Gordon F., Feig Sa, H I Libshitz, et al.. (1976). Mass screening for breast disease. Results, problems, and expectations.. Library Stack (Library Stack). 48(2). 137–41. 3 indexed citations
20.
Schwartz, Gordon F., et al.. (1976). Carcinoma of the breast in young women. The American Journal of Surgery. 131(5). 570–574. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Eva Singletary Breakdown of academic impact, for papers by Nora Hansen Breakdown of academic impact, for papers by C.W. Elston Breakdown of academic impact, for papers by David W. Kinne Breakdown of academic impact, for papers by Isabel T. Rubio Breakdown of academic impact, for papers by Mauro G. Mastropasqua Breakdown of academic impact, for papers by R. Douglas Macmillan Breakdown of academic impact, for papers by James Geraghty Breakdown of academic impact, for papers by Bernd Gerber Breakdown of academic impact, for papers by Karin Zedeler
Rankless by CCL
2026